Why Phreesia Stock Tumbled Today
Phreesia (PHR) shares fell 6.33% after reporting Q2 2027 revenue of $129.5M, up 10% YoY, and GAAP net income of $1.9M. While revenue beat estimates, earnings per share missed expectations. The company maintained full-year guidance and highlighted recent product launches.
How this was made

The 30-second read
Why it matters
Earnings miss triggered a 6% decline; guidance remains flat, suggesting limited upside unless new products accelerate.
Market read
The earnings release provides fresh data for traders; the stock's price reaction indicates immediate trading relevance.
What to watch
New AccessOne financing product and ProviderConnect platform may drive future revenue beyond current guidance.
Background
Phreesia is a next‑generation healthcare technology firm that automates patient‑doctor interactions.
Ticker impact
Phreesia reported Q2 FY2027 revenue of $129.5M and GAAP net income of $1.9M, missing consensus EPS of $0.09, causing a 6% stock drop.
Further downside pressure if guidance remains unchanged; short‑term bounce possible on any upside surprise.
The miss versus consensus EPS and modest top‑line beat are fresh data; market reaction already shows a 6% decline, indicating sensitivity to earnings.
Market effects
Healthcare tech may see broader scrutiny as earnings miss highlights margin pressure.
U.S. small‑cap healthcare tech segment could face slight pullback.
Limited to investors tracking digital health providers.
Counterpoint
If the restructuring yields cost savings, the stock could rebound on the back of long‑term growth potential.
Key entities
- companyPhreesia
Healthcare technology provider reporting Q2 FY2027 results.




